Article
Second malignant neoplasms in patients with Cowden syndrome with underlying germline PTEN mutations.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology - 10 Jun 2014
Ngeow Joanne, Stanuch Kim, Mester Jessica L, Barnholtz-Sloan Jill S, Eng Charis
Abstract excerpt
PURPOSE: Patients with Cowden syndrome (CS) with underlying germline PTEN mutations are at increased risk of breast, thyroid, endometrial, and renal cancers. To our knowledge, risk of subsequent cancers in these patients has not been previously explored or quantified. PATIENTS AND METHODS: We conducted a 7-year multicenter prospective study (2005 to 2012) of patients with CS or CS-like disease, all of whom...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
